当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析

易瑞生物

(300942)

  

流通市值:31.23亿  总市值:31.23亿
流通股本:4.05亿   总股本:4.05亿

易瑞生物(300942)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.10亿元,每股收益-0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益89942.19万元,未分配利润14997.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产148796.21万元,负债58854.02万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入57,644,102.49263,229,020.8185,633,642.05109,287,425.22
营业总成本73,515,702.11260,412,512.64181,665,643.9109,966,393.45
其他经营收益
营业利润-13,144,924.515,577,907.9316,671,226.8460,431.88
利润总额-13,090,611.3613,288,905.6216,988,453.86645,747.18
净利润-10,485,725.715,466,356.7618,807,119.871,889,832.3
每股收益
其他综合收益-217,813.54160,162.48-108,226.4435,823.62
综合收益总额-10,703,539.2415,626,519.2418,698,893.431,925,655.92
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计798,255,225.43817,814,250.15775,373,728.96702,228,403.82
非流动资产:
非流动资产合计689,706,895.03706,733,614.44706,186,305.89717,925,976.71
资产总计1,487,962,120.461,524,547,864.591,481,560,034.851,420,154,380.53
流动负债:
流动负债合计109,458,166.26160,703,352.59150,304,279.47109,475,500.98
非流动负债:
非流动负债合计479,082,080.16456,164,030.14420,904,074.09445,258,578.95
负债合计588,540,246.42616,867,382.73571,208,353.56554,734,079.93
所有者权益(或股东权益):
归属于母公司股东权益合计893,621,562.52904,080,226.3908,090,377.01864,392,737.31
股东权益合计899,421,874.04907,680,481.86910,351,681.29865,420,300.6
负债和股东权益合计1,487,962,120.461,524,547,864.591,481,560,034.851,420,154,380.53
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计81,199,577.14344,052,768.69206,284,991.21129,013,940.7
经营活动现金流出小计93,727,023.75277,180,954.85198,456,014.85129,034,293.16
经营活动产生的现金流量净额-12,527,446.6166,871,813.847,828,976.36-20,352.46
投资活动产生的现金流量:
投资活动现金流入小计110,633,165.49866,005,376.48741,477,443.1382,285,490.65
投资活动现金流出小计82,314,399.09827,495,842.8586,485,714.74257,264,464.67
投资活动产生的现金流量净额28,318,766.438,509,533.68154,991,728.36125,021,025.98
筹资活动产生的现金流量:
筹资活动现金流入小计24,770,781.2827,328,827.6226,928,827.625,928,827.62
筹资活动现金流出小计15,121,932.4854,846,231.0451,094,548.1246,129,653.35
筹资活动产生的现金流量净额9,648,848.8-27,517,403.42-24,165,720.5-40,200,825.73
汇率变动对现金及现金等价物的影响-6,680,492.72986,297.223,204,826.714,472,755.28
现金及现金等价物净增加额18,759,675.8778,850,241.32141,859,810.9389,272,603.07
期末现金及现金等价物余额354,741,876.61335,982,200.74398,991,770.35346,404,562.49
补充资料:
现金及现金等价物的净增加额-78,850,241.32-89,272,603.07
TOP↑